Clicky

ABL Bio Inc(298380)

Description: ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.


Keywords: Biotechnology Cancer Life Sciences Immunotherapy Cancer Immunotherapy Compugen

Home Page: www.ablbio.com

16 Daewangpangyo-Ro 712 Beon-Gil
Seongnam, 13488
South Korea
Phone: 82 31 8018 9800


Officers

Name Title
Dr. Sang Hoon Lee Founder & CEO
Mr. Jaecheon Lee MD & CFO
Jung Dae Kim MD & COO
Mr. You Weon-Kyoo Head of R&D and MD
Jae Ho Jung Ph.D. MD & Head of Discovery
Jong Ran Kim MD & Head of Clinical Devel.
Jong Hwa Won Ph.D. Head of Early Devel.

Exchange: KQ

Country: KR

Currency: Korean Won (₩)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 101.3769
IPO Date:
Fiscal Year End: December
Full Time Employees: 0
Back to stocks